ClinicalTrials.gg
CompletedNCT03727984BoomerangACSUpdated Jan 23, 2020

Re-hospitalized Patients With Acute Coronary Syndrome

An observational study in Acute Coronary Syndrome, sponsored by Cardiovascular Academy Society, Turkey. Completed at 1 site in Turkey. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2020-01-23.

Sponsored by Cardiovascular Academy Society, Turkey · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
577
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The predictors of re-hospitalization of patients with history of acute coronary syndrome

Read the detailed description

The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months.

02

Conditions studied

  • Acute Coronary Syndrome

Keywords

  • Myocardial infarction
  • Hospitalization
  • Coronary artery disease
  • Retrospective
  • Cohort study
03

In context

Acute Coronary Syndrome

1,488 studies on the registry are indexed under Acute Coronary Syndrome; 273 are open to participants now.

This study's enrollment of 577 is above the median of 500 across 590 observational studies indexed under Acute Coronary Syndrome.

Browse Acute Coronary Syndrome studies →

Lead sponsor

Cardiovascular Academy Society, Turkey is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months. To the best of our knowledge, this is the first study to evaluate the characteristics of re-hospitalized patients for ACS. The case report forms which attached in excel must be filled by investigators case by case based on recorded data.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients age >18 years who had hospitalized for acute coronary syndrome within 12 months

Exclusion criteria

Exclusion Criteria:

Patients whose previous hospitalizations data are not available Myocardial Infarction, type 2 patients

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
577 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Clinical and demographics characteristics of patients re-admitted with acute coronary syndrome

    The demographics and clinical characteristics of study population Admissions with an 'I'-group ICD-10 code

    Time frame: Up to 1 year

  2. Cardiovascular Hospitalization

    Predictive factors for patients re-admitted with acute coronary

    Time frame: Up to 1 year

07

Study locations

1 site
  • Cardiovascular Academy Society
    İzmir, Turkey
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2018 to primary completion in Sep 2019, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2018
First posted
Nov 1, 2018
StartActual
Nov 15, 2018
Primary completionActual
Sep 15, 2019
CompletionActual
Nov 15, 2019
Last update
Jan 23, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03727984
Lead sponsor
Cardiovascular Academy Society, Turkey
Responsible party
Mehdi Zoghi (Prof. Dr., Cardiovascular Academy Society, Turkey) — Principal investigator
First posted
Nov 1, 2018
Start date
Nov 15, 2018
Primary completion
Sep 15, 2019
Completion
Nov 15, 2019
Last update
Jan 23, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion